Article in ACS infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed.
CMPK2 restrictsbioRxiv : the preprint server for biology · 2026
John K NeffDepartment of Internal Medicine, University of Texas Southwestern Medical Center Dallas, Dallas, Texas 75390, United States.
Kristen E DeMeesterDepartment of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States.
Paola K Párraga SolórzanoDepartment of Internal Medicine, University of Texas Southwestern Medical Center Dallas, Dallas, Texas 75390, United States.
Radu M SuciuDepartment of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States.
Melissa M DixDepartment of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States.
Gabriel SimonVividion Therapeutics, San Diego, California 92121, United States.
Max A GianakopoulosLafayette College, Easton, Pennsylvania 18042, United States.
Bruno MelilloDepartment of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States.ORCID 0000-0002-9708-5287
Benjamin F CravattDepartment of Chemistry, The Scripps Research Institute, La Jolla, California 92037, United States.ORCID 0000-0001-5330-3492
Michael U ShilohDepartment of Internal Medicine, University of Texas Southwestern Medical Center Dallas, Dallas, Texas 75390, United States.ORCID 0000-0003-4329-2253
Funding
RP5: Chemical proteomic discovery of small-molecule probes for autophagy proteinsU19AI142784 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI CRAVATT, BENJAMIN F · 2019 to 2023
$36.9M
MOLECULAR MICROBIOLOGY TRAINING GRANTT32AI007520 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI Julie K Pfeiffer · 1997 to 2026
Innate immune cells, such as monocytes and macrophages, provide the earliest defense against intracellular pathogen infection by initiating signaling pathways and restricting pathogen replication. However, the full complement of proteins that mediate cell-autonomous immunity remains incompletely defined. Here, we applied cysteine-directed activity-based protein profiling (ABPP) to map proteome-wide cysteine reactivity changes in THP-1 monocytes and primary human monocyte-derived macrophages during
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Cysteine Reactivity Profiling Identifies Host Regulators of · full record | OpenQuestion